šŸ“šDefinitionsĀ 

Allergic Rhinitis: Inflammatory nasal condition caused by immune hypersensitivity to allergens (e.g., pollen, dust mites), characterized by:

  • Sneezing, nasal congestion, rhinorrhea (clear or yellow), itchy eyes/nose.
  • Symptoms typically occur within minutes of allergen exposure.

Ā 

šŸ”‘ Key Points

  • Prevalence: Affects 10–30% of children/adults in the U.S.; often persists from childhood into adulthood.
  • Comorbidities: Linked to asthma (33% of patients), sinusitis, and sleep disturbances.
  • Environmental controls are foundational to management.

Ā 

āœļø AssessmentĀ Ā 

History

  • Symptoms: Itching (nose/eyes), sneezing, congestion, postnasal drip, fatigue.
  • Triggers: Pollen (seasonal), dust mites, pet dander (perennial).
  • Red flags: Unilateral symptoms (rule out polyps/foreign body), fever (suggests infection).
  • Risk factors: Family history of atopy, young age (rare <2 years).

Examination (Telehealth Adaptations)

  • Eyes: Allergic shiners (infraorbital darkening), conjunctival injection.
  • Nose: Transverse crease ("allergic salute"), pale/bluish nasal mucosa.
  • Throat: Cobblestoning (posterior pharynx), clear postnasal drip.

Ā 

šŸŽÆ Differential DiagnosisĀ 

šŸ’† TreatmentĀ 

Ā 

  • Environmental Controls
  • Outdoors: Close windows during high pollen counts; shower after exposure.

    Ā 

  • Indoors:
  1. Ā 
    1. Dust mite covers for bedding; wash linens in hot water weekly.
    2. Dehumidify (<50% humidity); remove carpets if possible.
    3. Pet avoidance or weekly bathing (for pet allergies).

      Ā 

Ā 

Pharmacologic Therapy

Ā 

First-Line (Mild/Moderate Symptoms)

  • Intranasal Corticosteroids (INS):
  • Examples: Fluticasone (OTC), triamcinolone (OTC), budesonide (Rx).
  • Onset: 12–24 hours; maximal effect in 3–7 days.

    Ā 

  • Second-Generation Oral Antihistamines:
  1. Ā 
    1. Examples: Cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra).

Ā 

Add-On Therapies (Severe/Refractory Symptoms)

  1. Antihistamine Nasal Sprays: Azelastine (Astelin) or olopatadine (Patanase).
  2. Leukotriene Receptor Antagonists: Montelukast (especially if asthma coexists).
  3. Decongestants: Short-term use only (≤3 days; avoid in hypertension).

Ā 

Avoid:

  1. First-gen antihistamines (e.g., diphenhydramine) due to sedation.
  2. Prolonged decongestant sprays (risk of rhinitis medicamentosa).

Ā 

🚨 Special Considerations

  • Pregnancy: Cetirizine/loratadine (Category B) preferred.ase).

Ā 

šŸ“© Referral IndicatorsĀ 

  • Allergy testing/immunotherapy: For perennial symptoms unresponsive to therapy.
  • ENT evaluation: Unilateral symptoms, suspected structural abnormalities.

Ā 

Ā šŸ”® Follow UpĀ 

  • Expected response: Improvement within 2 weeks.
  • Preemptive therapy: Start INS 2–4 weeks before pollen season for recurrent cases.

Ā 

šŸ“˜ Coding

ICD-10 Codes:Ā 

  • J30.1: Pollen-induced allergic rhinitis
  • J30.81: Animal dander-induced allergic rhinitis

Ā 

If you have any questions or would like more information, please reach out to the Delegating Physician.Ā